These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 35003086

  • 21. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H.
    Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
    [Abstract] [Full Text] [Related]

  • 22. Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis.
    Chauvin P, Morzadec C, de Latour B, Llamas-Gutierrez F, Luque-Paz D, Jouneau S, Vernhet L.
    Innate Immun; 2022 Apr; 28(3-4):138-151. PubMed ID: 35522300
    [Abstract] [Full Text] [Related]

  • 23. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

  • 24. M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients.
    Hu W, Lin J, Lian X, Yu F, Liu W, Wu Y, Fang X, Liang X, Hao W.
    Clin Immunol; 2019 Aug; 205():8-15. PubMed ID: 31078708
    [Abstract] [Full Text] [Related]

  • 25. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 26. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 27. Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.
    Ye H, Wang LY, Zhao J, Wang K.
    World J Gastroenterol; 2013 May 14; 19(18):2818-25. PubMed ID: 23687420
    [Abstract] [Full Text] [Related]

  • 28. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec 14; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 29. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.
    Frantz C, Pezet S, Avouac J, Allanore Y.
    Dis Markers; 2018 Dec 14; 2018():8509583. PubMed ID: 29805720
    [Abstract] [Full Text] [Related]

  • 30. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Tasaki Y, Ohta K, Yachie A, Wada T.
    Pediatr Res; 2021 Feb 14; 89(3):667-672. PubMed ID: 32408340
    [Abstract] [Full Text] [Related]

  • 31. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA, Vasculitis Clinical Research Consortium.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):283-291. PubMed ID: 30380100
    [Abstract] [Full Text] [Related]

  • 32. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y.
    Clin J Am Soc Nephrol; 2012 Sep 01; 7(9):1385-93. PubMed ID: 22700887
    [Abstract] [Full Text] [Related]

  • 33. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
    Jensen TO, Schmidt H, Møller HJ, Høyer M, Maniecki MB, Sjoegren P, Christensen IJ, Steiniche T.
    J Clin Oncol; 2009 Jul 10; 27(20):3330-7. PubMed ID: 19528371
    [Abstract] [Full Text] [Related]

  • 34. Soluble CD163.
    Møller HJ.
    Scand J Clin Lab Invest; 2012 Feb 10; 72(1):1-13. PubMed ID: 22060747
    [Abstract] [Full Text] [Related]

  • 35. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
    Kondelkova K, Krejsek J, Borska L, Fiala Z, Hamakova K, Andrys C.
    Allergol Immunopathol (Madr); 2013 Feb 10; 41(3):158-62. PubMed ID: 22765877
    [Abstract] [Full Text] [Related]

  • 36. Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status.
    Liu X, Gong S, Ning Y, Li Y, Zhou H, He L, Lin L, Jin S, Shen Z, Zhu B, Li F, Li J, Tan X, Jiao X, Shi Y, Ding X.
    BMC Nephrol; 2023 Jul 14; 24(1):208. PubMed ID: 37452282
    [Abstract] [Full Text] [Related]

  • 37. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.
    Kjærgaard AG, Rødgaard-Hansen S, Dige A, Krog J, Møller HJ, Tønnesen E.
    PLoS One; 2014 Jul 14; 9(3):e92331. PubMed ID: 24637679
    [Abstract] [Full Text] [Related]

  • 38. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
    Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H.
    Clin Transl Gastroenterol; 2021 Mar 01; 12(3):e00315. PubMed ID: 33646203
    [Abstract] [Full Text] [Related]

  • 39. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M.
    Liver Int; 2016 Nov 01; 36(11):1628-1638. PubMed ID: 27031405
    [Abstract] [Full Text] [Related]

  • 40. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications.
    Adly AAM, Ismail EAR, Ibraheem TM.
    Int Immunopharmacol; 2015 Feb 01; 24(2):416-422. PubMed ID: 25587690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.